Do generics producers have what it takes to tackle complex and specialty drugs?
Complex and specialty generics offer high rewards, but their development also comes with operational risks.
By
Drug Manufacturers
Latest in
Drug Manufacturers
ARS Pharmaceuticals to merge with Silverback Therapeutics
The combined company will focus on obtaining regulatory clearance and commercialisation of ARS’ neffy nasal spray.
California’s low-cost insulin plans receive $100m manufacturing boost
Governor Newsom unveils plans to work with a CMO to produce low-cost insulin, even though most insulin is currently produced…
By
CMO Moves: Regulatory catalysts for drug manufacturing-July
Pharmaceutical Technology does a roundup of regulatory decisions from late April to early May that impact drugs and the CMOs…
By
Russia’s focus on domestic pharma production could shield it from sanctions’ effects
Russia’s pharma manufacturing is more focused on the domestic market due to its comparative lack of FDA and EMA approvals.
By
Rare Disease Spotlight – tracing the rise of orphan drug designations over almost 40 years
In the first edition of Pharmaceutical Technology’s series on the FDA’s orphan drug program, we examine how its popularity has…
By
Non-stop investment from CMOs and US Government into continuous manufacturing
CMOs have been increasingly adopting the use of continuous manufacturing for biologics production following FDA approval.
By
Alto Neuroscience uses AI to create biomarkers for personalised mental health drugs
GlobalData’s Drugs Database reveals that more than 490 unique drugs have been discovered using AI-based technologies.
By